Grove Matsuoka - Net Worth and Insider Trading
Grove Matsuoka Net Worth
The estimated net worth of Grove Matsuoka is at least $1,499 dollars as of 2024-05-11. Grove Matsuoka is the See Remarks of aTyr Pharma Inc and owns about 887 shares of aTyr Pharma Inc (LIFE) stock worth over $1,499. Details can be seen in Grove Matsuoka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Grove Matsuoka has not made any transactions after 2016-05-11 and currently still holds the listed stock(s).
Transaction Summary of Grove Matsuoka
Grove Matsuoka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Grove Matsuoka owns 1 companies in total, including aTyr Pharma Inc (LIFE) .
Click here to see the complete history of Grove Matsuoka’s form 4 insider trades.
Insider Ownership Summary of Grove Matsuoka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LIFE | aTyr Pharma Inc | 2016-05-11 | See Remarks |
Grove Matsuoka Latest Holdings Summary
Grove Matsuoka currently owns a total of 1 stock. Grove Matsuoka owns 887 shares of aTyr Pharma Inc (LIFE) as of May 11, 2016, with a value of $1,499.
Latest Holdings of Grove Matsuoka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LIFE | aTyr Pharma Inc | 2016-05-11 | 887 | 1.69 | 1,499 |
Holding Weightings of Grove Matsuoka
Grove Matsuoka Form 4 Trading Tracker
According to the SEC Form 4 filings, Grove Matsuoka has made a total of 0 transactions in aTyr Pharma Inc (LIFE) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the acquisition of 887 shares on May 11, 2016, which cost Grove Matsuoka around $37,733.
Insider Trading History of Grove Matsuoka
- 1
Grove Matsuoka Trading Performance
GuruFocus tracks the stock performance after each of Grove Matsuoka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Grove Matsuoka is 6.98%. GuruFocus also compares Grove Matsuoka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Grove Matsuoka within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Grove Matsuoka's insider trading performs compared to the benchmark.
Performance of Grove Matsuoka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.99 | | | | | |
| Relative Return to S&P 500(%) | 0.46 | | | | | |
Grove Matsuoka Ownership Network
Grove Matsuoka Owned Company Details
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Grove Matsuoka is the See Remarks of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (LIFE) Insider Trades Summary
Over the past 18 months, Grove Matsuoka made no insider transaction in aTyr Pharma Inc (LIFE). Other recent insider transactions involving aTyr Pharma Inc (LIFE) include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (LIFE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (LIFE) were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.
aTyr Pharma Inc (LIFE)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
Grove Matsuoka Mailing Address
Above is the net worth, insider trading, and ownership report for Grove Matsuoka. You might contact Grove Matsuoka via mailing address: C/o Atyr Pharma, Inc., 3545 John Hopkins Court, Suite 250, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
